Media outlets including Los Angeles Times, The Hollywood Reporter, Yahoo! Life, and more, have covered the news of Amazon MGM Studios’ Debra Birnbaum joining the Ovarian Cancer Research Alliance (OCRA) Board of Directors. The coverage highlights her extensive background in media and her personal connection to ovarian cancer, and underscores the significant contributions Birnbaum is poised to make in furthering OCRA’s mission.
Related Topics
Action Alert: Urge Congress to Pass Final Bill on Cancer Research Funding and Early Detection
The Congressional Appropriations Committees have released a combined FY2026 Defense/Labor, Health and Human Services bill—and it includes several critical investments and policy provisions that would significantly strengthen the federal response to ovarian and other gynecologic cancers. This bill represents meaningful progress for our community, but it is not final. Congress must act swiftly to advance and … Continued
OCRA Urges Immediate Passage of Bill Supporting Ovarian Cancer Research, Education, and Early Detection
The Ovarian Cancer Research Alliance today praised the release of the FY2026 Labor, Health and Human Services, Education, and Related Agencies appropriations bill by the Congressional Appropriations Committees and urged swift action to advance and enact the legislation. The bill includes critical funding and policy provisions supporting ovarian cancer research, education, and early detection. Add Your Voice … Continued
Ovarian Cancer Research Alliance Reports Year of Significant Progress Across Research, Advocacy, and Patient Support
Organization launches global initiatives, expands patient programs, strengthens policy leadership, and achieves record engagement in 2025 OCRA is grateful for our community’s generous support, which helped raise over $2.4 million, surpassing our year-end campaign goal and closing out a year of progress. NEW YORK, NY — [January 13, 2026] — In 2025, Ovarian Cancer Research Alliance (OCRA) delivered … Continued